Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Amyloidoses

Heart complaints can give first indication

    • Allergology and clinical immunology
    • Cardiology
    • Hematology
    • Infectiology
    • News
    • Oncology
    • Pediatrics
    • RX
  • 3 minute read

In the field of rare diseases, there is an enormous need to catch up in terms of knowledge, correct diagnosis and therapy. Many primary care physicians are also feeling this right now. After all, what general practitioner would think of light chain (AL) amyloidosis when the patient comes to the office with symptoms that would be diagnosed as mild heart failure on the face of it?

Unfortunately, it often takes a long time until an adequate diagnosis of amyloidosis is made. Patients feel this firsthand because the complaints are steadily increasing. Light-chain amyloidosis is a rare disease and the symptoms are unclear, so that even specialists cannot always classify them immediately. However, because AL amyloidosis is progressive and organ damage increases, rapid and correct diagnosis is central.

Epidemiology

In industrialized countries, AL amyloidosis is the most common form of amyloidosis. Triggers are pathologically increased plasma cells or, rarely, lymphocytes. The antibodies produced as a result are defectively formed in one of the light chains. These therefore clump together and the resulting amyloid is deposited as poorly soluble fibrils in organs. The heart muscles, gastrointestinal tract, kidneys, liver and spleen are particularly often affected. However, unusual tongue swelling along with heart failure may also provide a clue for a more specific diagnosis.

There is a risk of misdiagnosis

Causes of AL amyloidosis include monoclonal gammopathies, previously diagnosed malignant blood disorders, or lymph node disease. However, it can also occur without such and therefore often remains undetected for a very long time in older people. This is also because the classic symptoms, such as shortness of breath, dysrhythmia or edema in the legs, may initially lead to a different diagnosis. However, if additional symptoms such as low blood pressure, weakness, foamy urine, upper abdominal discomfort, numbness or tingling and even stabbing pain, an enlarged tongue and bleeding in the skin around the eyes appear, it is imperative that clarification by a specialist be initiated.

What therapies are available?

Therapeutically, there are so far only limited options for the oncologist. These include moderate to severe chemotherapy in combination with cortisone or stem cell therapy aimed at destroying the bone marrow with reduction of plasma or lymphocytes and antibodies. The severity of chemotherapy here depends on the patient’s age, general condition, and organ resilience. Thalidomide is also used for therapy. However, there is also a potential for side effects here.

Unfortunately, often the side effects of chemotherapy are so severe that patients discontinue it because of them. What other therapies will be available in the future is still uncertain. However, various competence centers are involved in research projects. In a few cases, a few of the symptoms could be alleviated. However, the lost kidney function cannot be restored. Therefore, rapid diagnosis and possible therapeutic intervention is critical to the patient’s quality of life.

In addition to these attempts to halt AL amyloidosis, supportive treatment should be given to the affected organ systems. Here, the informed family doctor takes over the further therapy.

Hopefully, with the increase in knowledge about rare diseases, primary care physicians will be better equipped to consider amyloidosis as a differential diagnosis in the future.

Share and discuss your experiences: Orphanbiotec blog under the topic amyloidosis.
www.blog.orphanbiotec-foundation.com

 

HAUSARZT PRAXIS 2014; 9(7): 55-56

Partner
  • 20151013_orphan-logo_de
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • AL amyloidosis
  • Heart failure
  • Light chains
  • Orphan Biotec
  • rare diseases
Previous Article
  • Insulin in type 2 diabetes

When and in which combination?

  • Congress Reports
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Partner Content
  • RX
View Post
Next Article
  • Immuno-Oncology

New pathways for improved cancer treatment?

  • Congress Reports
  • Oncology
  • RX
View Post
You May Also Like
View Post
  • 6 min
  • Latent autoimmune diabetes in adults (LADA)

Looks like type 2, but is type 1

    • Cases
    • Education
    • Endocrinology and Diabetology
    • RX
    • Studies
View Post
  • 6 min
  • Treatment of vitiligo

Focus on patient perspective and disease activity

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Vaccine-preventable respiratory diseases

RSV and pneumococci: recommendations for risk groups

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pediatrics
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Circadian rhythm in asthma

Chronotherapy can improve control

    • Allergology and clinical immunology
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • Update on diagnostics, risk stratification and therapy

Acute myeloid leukemia 2025

    • Education
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 5 min
  • Findings from the TRACK-FA study

Neuroimaging biomarkers in Friedreich’s ataxia

    • Genetics
    • Neurology
    • Pediatrics
    • RX
    • Studies
View Post
  • 12 min
  • Doing sport without fear or risk

Doing sport without fear or risk

    • CME continuing education
    • Endocrinology and Diabetology
    • Pediatrics
    • RX
    • Sports Medicine
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Doing sport without fear or risk
  • 2
    UV protection and skin cancer screening – Update 2025
  • 3
    Rare malignancy from a dermatological perspective
  • 4
    Yellow nail and Swyer-James syndrome
  • 5
    Diagnostic indications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.